Skip to main content

Alissa Interpret streamlines clinical lab workflows across applications and technologies

Increasingly sophisticated technologies such as NGS panels, exomes, whole genomes and microarrays are being introduced in routine testing in both clinical genetics and molecular pathology. Lab managers face the challenge to efficiently implement these novel technologies in their routine workflow, reaching fast turnaround times while at the same time ensuring variant assessment and reporting happens at the highest possible clinical standards.

Alissa Interpret for Clinical Genetics

Clinical-grade variant assessment and reporting for inherited diseases

Alissa Interpret for Molecular Pathology

Clinical-grade somatic variant assessment and reporting

Alissa Interpret is a USA Class I Exempt Medical Device, Europe CE IVD, Canada and Australia Class I IVD Device.